Terms ending in 2041
Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,109,308 | Aqueous Formulation Comprising 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-Dimorpholin-4-YL-1,3,5-Triazin-2-YL)PHENYL]UREA In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 12,121,588 | Large Scale Production Process for Capped and Un-Capped Antibody Cysteines and Their Use in Therapeutic Protein Conjugation In force · High confidence | Pfizer, Inc. | In force | High confidence | |
| US 12,458,689 | Escherichia Coli Compositions and Methods Thereof In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 11,597,770 | Anti-E-Selectin Antibodies, Compositions and Methods of Use In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,673,953 | DLL3 Targeting Chimeric Antigen Receptors and Binding Agents In force · High confidence | Allogene Therapeutics, Inc. | In force | High confidence | |
| US 12,606,623 | DLL3 Targeting Chimeric Antigen Receptors and Binding Agents In force · High confidence | Pfizer Inc. and Allogene Therapeutics, Inc. | In force | High confidence | |
| US 11,993,625 | Calicheamicin Derivatives and Antibody Drug Conjugates Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,661,419 | Benzimidazole Derivative Compounds and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,702,474 | Antibodies Specific for CD47, PD-L1, and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 12,227,507 | Pharmaceutical Compounds In force · High confidence | Pfizer Inc. | In force | High confidence | |
| 21 more term ends in 2041 · Pro | |||||
10 of 31 patents shown. Soonest term end first, then patent number.
Pro members see all 31.
29 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.